Webinar: HCP assays to improve risk mitigation

Posted: 11 August 2020 | | No comments yet

HCPs are critical to quality control in biologics development. If left unremoved, they can cause immunogenic responses and reduce drug efficacy.

Join Andrew Hamilton, Scientist on the Imaging and Western Blotting team at Cytiva, for the latest tips on designing a comprehensive HCP risk mitigation strategy. Our webinar will outline how to ensure accurate measurements, build confidence, and reduce the risk of unexpected HCP levels. Register (no cost)